ClinicalTrials.Veeva

Menu

Effects of Whole Body Vibration Therapy on Cognitive Function, Balance, and Quality of Life in Older Adults With Mild Cognitive Impairment

J

Jouf University

Status

Not yet enrolling

Conditions

Balance
Cognitive Impairment
Quality of Life

Treatments

Other: Control
Other: WBV Therapy Group
Other: Placebo Group:

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a double-blind, randomized controlled trial comparing WBV therapy with a placebo intervention and standard care. A total of 150 participants will be recruited and investigated from Prince Mutib Hospital. Participants will be randomly allocated to one of three groups: WBV therapy, placebo (non-vibrating platform), or control (standard care). The study duration will be 12 weeks, with assessments conducted at baseline, post-intervention (12 weeks), and at a 6-month follow-up.

Protocol Parameters Summary

  • Session Frequency: 3 times per week.
  • Session Duration: 25 minutes per session.
  • Vibration Frequency: 30 Hz.
  • Amplitude: 1-2 mm.
  • Program Duration: 12 weeks.

Enrollment

180 estimated patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults aged 60 years and older.
  • Diagnosed with mild cognitive impairment (Montreal Cognitive Assessment (MoCA) score of 18-25). One point is added if years of education are less than 12 years[2].
  • Able to stand independently or with minimal assistance.
  • No contraindications for WBV therapy or exercise.

Exclusion criteria

  • Diagnosis of dementia.
  • Severe musculoskeletal or neurological disorders.
  • Implanted electronic medical devices (e.g., pacemaker).
  • Inability to comprehend study instructions.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

180 participants in 3 patient groups, including a placebo group

WBV Therapy Group
Experimental group
Description:
* Frequency: 3 sessions per week for 12 weeks. * Duration: 25 minutes per session. * Vibration Parameters: Participants will undergo whole body vibration therapy at a frequency of 30 Hz, for 25 minutes per session, 3 times a week, with an amplitude of 1-2 mm, over a duration of 12 weeks.
Treatment:
Other: WBV Therapy Group
Other: Control
Placebo Group
Placebo Comparator group
Description:
• Participants will stand on a non-vibrating platform and perform similar static and dynamic exercises for the same duration. The platform will mimic the active intervention's noise and display settings to maintain blinding.
Treatment:
Other: Placebo Group:
Control Group
No Intervention group
Description:
Only assessment at baseline, after 12 weeks and 6 months.

Trial contacts and locations

0

Loading...

Central trial contact

Fahad Alanazi, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems